Cornerstone Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Sell |
5,644
-1,220
| -18% | -$84.2K | 0.02% | 442 |
|
|
2025
Q1 | $477K | Buy |
6,864
+1,275
| +23% | +$88.5K | 0.03% | 376 |
|
|
2024
Q4 | $481K | Buy |
5,589
+1,183
| +27% | +$102K | 0.03% | 363 |
|
|
2024
Q3 | $525K | Sell |
4,406
-217
| -5% | -$25.8K | 0.04% | 342 |
|
|
2024
Q2 | $660K | Buy |
4,623
+295
| +7% | +$42.1K | 0.05% | 270 |
|
|
2024
Q1 | $556K | Sell |
4,328
-60
| -1% | -$7.7K | 0.05% | 313 |
|
|
2023
Q4 | $454K | Sell |
4,388
-1,016
| -19% | -$105K | 0.04% | 334 |
|
|
2023
Q3 | $491K | Buy |
5,404
+1,526
| +39% | +$139K | 0.05% | 312 |
|
|
2023
Q2 | $314K | Sell |
3,878
-168
| -4% | -$13.6K | 0.03% | 392 |
|
|
2023
Q1 | $322K | Buy |
+4,046
| New | +$322K | 0.03% | 362 |
|
|
2022
Q3 | $397K | Sell |
7,964
-86
| -1% | -$4.29K | 0.04% | 301 |
|
|
2022
Q2 | $448K | Sell |
8,050
-30
| -0.4% | -$1.67K | 0.05% | 283 |
|
|
2022
Q1 | $449K | Sell |
8,080
-1,268
| -14% | -$70.5K | 0.04% | 293 |
|
|
2021
Q4 | $523K | Buy |
9,348
+4,384
| +88% | +$245K | 0.05% | 277 |
|
|
2021
Q3 | $238K | Buy |
4,964
+86
| +2% | +$4.12K | 0.03% | 402 |
|
|
2021
Q2 | $204K | Buy |
+4,878
| New | +$204K | 0.02% | 455 |
|
|
2018
Q4 | – | Sell |
-413,368
| Closed | -$4.2M | – | 889 |
|
|
2018
Q3 | $4.2M | Buy |
413,368
+109,242
| +36% | +$1.11M | 0.05% | 331 |
|
|
2018
Q2 | $3.25M | Buy |
+304,126
| New | +$3.25M | 0.04% | 407 |
|
|
2018
Q1 | – | Sell |
-8,744
| Closed | -$239K | – | 414 |
|
|
2017
Q4 | $239K | Buy |
8,744
+344
| +4% | +$9.4K | 0.04% | 347 |
|
|
2017
Q3 | $207K | Sell |
8,400
-1,840
| -18% | -$45.3K | 0.04% | 362 |
|
|
2017
Q2 | $216K | Buy |
+10,240
| New | +$216K | 0.05% | 339 |
|